Cargando…
Bone marrow mononuclear stem cells: potential in the treatment of myocardial infarction
Despite advances in the management of myocardial infarction, congestive heart failure following myocardial infarction continues to be a major worldwide medical problem. Mononuclear cells from bone marrow are currently being studied as potential candidates for cell-based therapy to repair and regener...
Autores principales: | Leblond, Anne-Laure, O’Sullivan, John, Caplice, Noel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3781688/ https://www.ncbi.nlm.nih.gov/pubmed/24198506 |
Ejemplares similares
-
Bone marrow mononuclear cells and acute myocardial infarction
por: Arnous, Samer, et al.
Publicado: (2012) -
Systemic and Cardiac Depletion of M2 Macrophage through CSF-1R Signaling Inhibition Alters Cardiac Function Post Myocardial Infarction
por: Leblond, Anne-Laure, et al.
Publicado: (2015) -
Fifteen years of bone marrow mononuclear cell therapy in acute myocardial infarction
por: Micheu, Miruna Mihaela, et al.
Publicado: (2017) -
Strengthening effects of bone marrow mononuclear cells with intensive atorvastatin in acute myocardial infarction
por: Yang, Yue-Jin, et al.
Publicado: (2020) -
A brief review: the therapeutic potential of bone marrow mesenchymal stem cells in myocardial infarction
por: Miao, Chi, et al.
Publicado: (2017)